In this article the possibility to detect adulteration of costly olive oils with cheaper vegetable oils using fluorescence spectroscopy is studied. Total luminescence spectra were recorded by measuring the emission spectra in the range 350 nm to 720 nm for excitation wavelengths from 375 nm to 450 nm. Fluorescence spectra of 12 types of olive oil samples were studied. Ten of the olive oil types were purchased locally, while two (samples 1 and 4) were obtained directly from Greek olive oil producers. Analysis of the fatty acid and the tocopherol contents has been performed. Two of the samples exhibit the content of sunflower oils, two are admixtures of sunflower and olive oils, while the remaining eight samples are natural olive oils. The samples show differences in their fluorescence spectra. The latter fact shows that fluorescence spectroscopy can be used for the quick identification of possible adulterations of olive oil, although a more detailed gas chromatographic analysis is needed for the exact quantitative determination of the content of the adulterant.
We are living in a time when the population of the Earth is increasing and the available resources are decreasing. The latter requires the establishment of a smart and sustainable bio-based economy, and the creation of such an economy is tightly associated with the implementation of innovations. Bulgarian wine industry is a sector, where possibilities of innovations related to bio-economy are vast and open. Thus, the current study aims at identifying the entrepreneurial endeavours and the innovations' involvement in the wine industry as a specific sector of the bio-based economy in Bulgaria. The results indicate that there is a potential for the introduction of bio innovations in the wine industry as the producers are willing to implement them. However, currently there are almost no innovations related to the bio-economy and the prevailing innovations in Bulgarian wine industry are the marketing ones.
We report the results of follow-up analyses of 12 genomic regions showing evidence of linkage in a genome-wide scan (GWS) of Gypsy families with bipolar affective disorder (BPAD). The Gypsies are a young founder population comprising multiple genetically differentiated sub-isolates with strong founder effect and limited genetic diversity. The BPAD families belong to a single sub-isolate and are connected by numerous inter-marriages, resulting in a super-pedigree with 181 members. We aimed to re-assess the positive GWS findings and search for evidence of a founder susceptibility allele after the addition of newly recruited subjects, some changes in diagnostic assignment, and the use of denser genetic maps. Linkage analysis was conducted with SimWalk2, accommodating the full complexity of pedigree structure and using a conservative narrow phenotype definition (BPAD only). Six regions were rejected, while 1p36, 13q31, 17p11, 17q21, 6q24, and 4q31 produced nominally significant results in both the individual families and the super-pedigree. Haplotypes were reconstructed and joint tests for linkage and association were done for the most promising regions. No common ancestral haplotype was identified by sequencing a strong positional and functional candidate gene (GRM1) and additional STR genotyping in the top GWS region, 6q24. The best supported region was a 12 cM interval on 4q31, also implicated in previous studies, where we obtained significant results in the super-pedigree using both SimWalk2 (P = 0.004) and joint Pseudomarker analysis of linkage and linkage disequilibrium (P = 0.000056). The size of the region and the characteristics of the Gypsy population make it suitable for LD mapping.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.